COMP <GO>
FTV vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Fortive Corporation Common Stock (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: FTV 7
— TMO 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
LAST: $65.23 (-0.93%) • MKT CAP: $19.60B
balance-sheet
3.23
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FTV VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FTV | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 63.50% | 41.00% | +22.50 | FTV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.80% | 9.30% | -2.50 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.6x | 30.4x | -3.80 | FTV | /valuation <GO> |
| Free Cash Flow Yield | 4.99% | 2.40% | +2.59 | FTV | /fcf-yield <GO> |
| Operating Margin | 17.30% | 17.40% | -0.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | 12.80% | 15.10% | -2.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 1.90% | 3.90% | -2.00 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.47% | 0.24% | +0.23 | FTV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.23 | 4.50 | -1.27 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.70% | +0.10 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 77.2 | 59.1 | +18.05 | FTV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.94 | +0.04 | FTV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.2x | 36.3x | -2.10 | FTV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $19.60B | $262.22B | -$242.62B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FTV REV | TMO REV | FTV GROSS % | TMO GROSS % | FTV FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.16B | $44.56B | 63.5% | 44.0% | $978.1M | $6.29B |
| FY 2024 | $4.08B | $42.88B | 64.2% | 44.0% | $1.44B | $7.27B |
| FY 2023 | $3.91B | $42.86B | 44.0% | 44.0% | $1.18B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FTV // BETA 0.98
TMO // BETA 0.94